The only human study that assessed the effect of cranberry supplementation in patients with NAFLD reported significant differences between cranberry and placebo groups regarding changes in ALT level but not AST and ALP levels [21]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.